ACLS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gu, X.-P.
Right arrow Articles by Ding, Y.-T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gu, X.-P.
Right arrow Articles by Ding, Y.-T.
Annals of Clinical & Laboratory Science 34:187-194 (2004)
© 2004 Association of Clinical Scientists

Pyrrolidine Dithiocarbamate Added to University of Wisconsin Solution Inhibits Reperfusion Injury after Orthotopic Liver Transplantation in Rats

Xiao-Ping Gu1, Fu-Tao Xu1, Yong Jiang2, Yu-Dong Qiu2 and Yi-Tao Ding2
1 Departments of Anesthesiology and 2 Hepatobiliary Surgery, Drum Tower Hospital, Medical School of Nanjing University, Nanjing, People’s Republic of China

Address correspondence to Yi-Tao Ding M.D., Department of Hepatobiliary Surgery, Drum Tower Hospital, Medical School of Nanjing University, Nanjing 210008, People’s Republic of China; tel 86 25 8330 4616, x10427; fax 86 25 8331 7016; e-mail yys982002{at}yahoo.com.cn.

This study investigated the effects of pyrrolidine dithiocarbamate (PDTC), a novel NF-{kappa}B inhibitor, on the expression of multiple inflammatory mediators and on neutrophilic inflammation of the graft in rats following liver transplantation. Orthotopic liver transplantation (OLT) was performed after 24 hr of cold storage using University of Wisconsin (UW) solution that contained various concentrations of PDTC. We determined the time course of NF-{kappa}B activation and of the expression of multiple inflammatory signals: tumor necrosis factor-{alpha} (TNF-{alpha}), cytokine-inducible neutrophil chemoattractant (CINC), and intercellular adhesion molecule-1 (ICAM)-1. Serum alanine aminotransferase (ALT), intrahepatic myeloperoxidase (MPO/ WBC ratio, a measure of neutrophil accumulation), and Mac-1 expression (CD11b/CD18, a measure of circulating neutrophil activity) were also evaluated. The results showed that PDTC decreased OLT-induced NF-{kappa}B activation in a dose-dependent manner (from 20 mmol/L to 60 mmol/L), diminished TNF-{alpha}, CINC, and ICAM-1 protein levels in the graft, and reduced the OLT-induced increase of serum TNF-{alpha} level. Pretreatment with PDTC significantly suppressed OLT-induced neutrophilic inflammation of the graft. The PDTC-exposed livers (PDTC, 40 mmol/L), in comparison with the control livers, had a significant reduction of MPO/WBC ratio (7.04±0.97 vs 14.07±1.31) and Mac-1 expression (181±11.3% vs 281±13.2%) at 6 hr after reperfusion. Furthermore, PDTC inhibited the increase of serum ALT levels after liver transplantation. In conclusion, PDTC inhibited NF-{kappa}B activation and the expression of the inflammatory mediators. These effects were associated with improved graft viability through inhibited intrahepatic neutrophilic inflammation. A therapeutic strategy directed at inhibition of NF-{kappa}B activation within the transplanted liver might be effective in reducing intrahepatic neutrophilic inflammation, and be beneficial to prolonged graft storage.

Keywords: liver transplantation, pyrrolidine dithiocarbamate, NF-{kappa}B, TNF-{alpha}, , inflammatory mediators







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the Association of Clinical Scientists.